These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies. Chartrain M; Chu L Curr Pharm Biotechnol; 2008 Dec; 9(6):447-67. PubMed ID: 19075685 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies: technologies for early discovery and engineering. Kennedy PJ; Oliveira C; Granja PL; Sarmento B Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584 [TBL] [Abstract][Full Text] [Related]
11. Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies. Yau KY; Lee H; Hall JC Biotechnol Adv; 2003 Oct; 21(7):599-637. PubMed ID: 14516873 [TBL] [Abstract][Full Text] [Related]
12. Beyond natural antibodies: the power of in vitro display technologies. Bradbury AR; Sidhu S; Dübel S; McCafferty J Nat Biotechnol; 2011 Mar; 29(3):245-54. PubMed ID: 21390033 [TBL] [Abstract][Full Text] [Related]
14. Development of yeast molecular display systems focused on therapeutic proteins, enzymes, and foods: functional analysis of proteins and its application to bioconversion. Shibasaki S; Ueda M Recent Pat Biotechnol; 2010 Nov; 4(3):198-213. PubMed ID: 21171957 [TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies, 30 years of success]. Laffly E; Sodoyer R J Soc Biol; 2006; 200(4):325-43. PubMed ID: 17652969 [TBL] [Abstract][Full Text] [Related]
16. Recombinant antibodies for cancer diagnosis and therapy. Hudson PJ; Souriau C Expert Opin Biol Ther; 2001 Sep; 1(5):845-55. PubMed ID: 11728219 [TBL] [Abstract][Full Text] [Related]
17. Antibody phage display: overview of a powerful technology that has quickly translated to the clinic. Kotlan B; Glassy MC Methods Mol Biol; 2009; 562():1-15. PubMed ID: 19554283 [TBL] [Abstract][Full Text] [Related]
18. Historical development of monoclonal antibody therapeutics. Nissim A; Chernajovsky Y Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939 [TBL] [Abstract][Full Text] [Related]
19. Agrobacterium-mediated transient expression as an approach to production of recombinant proteins in plants. Sheludko YV Recent Pat Biotechnol; 2008; 2(3):198-208. PubMed ID: 19075868 [TBL] [Abstract][Full Text] [Related]
20. Engineered proteins as specific binding reagents. Binz HK; Plückthun A Curr Opin Biotechnol; 2005 Aug; 16(4):459-69. PubMed ID: 16005204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]